Literature DB >> 32236885

Standardized Workflows Improve Colonoscopy Follow-Up After Abnormal Fecal Immunochemical Tests in a Safety-Net System.

Rachel B Issaka1,2,3, Carly Rachocki4, Michael P Huynh5, Ellen Chen6, Ma Somsouk4,7.   

Abstract

BACKGROUND: How clinical teams function varies across sites and may affect follow-up of abnormal fecal immunochemical test (FIT) results. AIMS: This study aimed to identify the characteristics of clinical practices associated with higher diagnostic colonoscopy completion after an abnormal FIT result in a multi-site integrated safety-net system.
METHODS: We distributed survey questionnaires about tracking and follow-up of abnormal FIT results to primary care team members across 11 safety-net clinics from January 2017 to April 2017. Surveys were distributed at all-staff clinic meetings and electronic surveys sent to those not in attendance. Participants received up to three reminders to complete the survey.
RESULTS: Of the 501 primary care team members identified, 343 (68.5%) completed the survey. In the four highest-performing clinics, nurse managers identified at least two team members who were responsible for communicating abnormal FIT results to patients. Additionally, team members used a clinic-based registry to track patients with abnormal FIT results until colonoscopy completion. Compared to higher-performing clinics, lower-performing clinics more frequently cited competing health issues (56% vs. 40%, p = 0.03) and lack of patient priority (59% vs. 37%, p < 0.01) as barriers and were also more likely to discuss abnormal results at a clinic visit (83% vs. 61%, p < 0.01).
CONCLUSIONS: Our findings suggest organized and dedicated efforts to communicate abnormal FIT results and track patients until colonoscopy completion through registries is associated with improved follow-up. Increased utilization of electronic health record platforms to coordinate communication and navigation may improve diagnostic colonoscopy rates in patients with abnormal FIT results.

Entities:  

Keywords:  Colorectal cancer; Diagnostic colonoscopy; Electronic health records; Fecal immunochemical test; Standardized workflows

Mesh:

Year:  2020        PMID: 32236885      PMCID: PMC7529734          DOI: 10.1007/s10620-020-06228-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  15 in total

1.  eReferral--a new model for integrated care.

Authors:  Alice Hm Chen; Elizabeth J Murphy; Hal F Yee
Journal:  N Engl J Med       Date:  2013-06-27       Impact factor: 91.245

2.  Inadequate Utilization of Diagnostic Colonoscopy Following Abnormal FIT Results in an Integrated Safety-Net System.

Authors:  Rachel B Issaka; Maneesh H Singh; Sachiko M Oshima; Victoria J Laleau; Carly D Rachocki; Ellen H Chen; Lukejohn W Day; Urmimala Sarkar; Ma Somsouk
Journal:  Am J Gastroenterol       Date:  2016-12-13       Impact factor: 10.864

3.  Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care.

Authors:  David T Liss; David W Baker
Journal:  Am J Prev Med       Date:  2014-03       Impact factor: 5.043

4.  Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies.

Authors:  John M Inadomi; Sandeep Vijan; Nancy K Janz; Angela Fagerlin; Jennifer P Thomas; Yunghui V Lin; Roxana Muñoz; Chim Lau; Ma Somsouk; Najwa El-Nachef; Rodney A Hayward
Journal:  Arch Intern Med       Date:  2012-04-09

5.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

Authors:  J S Mandel; J H Bond; T R Church; D C Snover; G M Bradley; L M Schuman; F Ederer
Journal:  N Engl J Med       Date:  1993-05-13       Impact factor: 91.245

6.  Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study.

Authors:  Christopher D Jensen; Douglas A Corley; Virginia P Quinn; Chyke A Doubeni; Ann G Zauber; Jeffrey K Lee; Wei K Zhao; Amy R Marks; Joanne E Schottinger; Nirupa R Ghai; Alexander T Lee; Richard Contreras; Carrie N Klabunde; Charles P Quesenberry; Theodore R Levin; Pauline A Mysliwiec
Journal:  Ann Intern Med       Date:  2016-01-26       Impact factor: 25.391

7.  Screening for colorectal cancer in a safety-net health care system: access to care is critical and has implications for screening policy.

Authors:  Samir Gupta; Liyue Tong; James E Allison; Elizabeth Carter; Mark Koch; Don C Rockey; Paula Anderson; Chul Ahn; Keith Argenbright; Celette Sugg Skinner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-09       Impact factor: 4.254

8.  Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems.

Authors:  Jessica Chubak; Michael P Garcia; Andrea N Burnett-Hartman; Yingye Zheng; Douglas A Corley; Ethan A Halm; Amit G Singal; Carrie N Klabunde; Chyke A Doubeni; Aruna Kamineni; Theodore R Levin; Joanne E Schottinger; Beverly B Green; Virginia P Quinn; Carolyn M Rutter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02       Impact factor: 4.254

9.  Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis.

Authors:  Douglas A Corley; Christopher D Jensen; Virginia P Quinn; Chyke A Doubeni; Ann G Zauber; Jeffrey K Lee; Joanne E Schottinger; Amy R Marks; Wei K Zhao; Nirupa R Ghai; Alexander T Lee; Richard Contreras; Charles P Quesenberry; Bruce H Fireman; Theodore R Levin
Journal:  JAMA       Date:  2017-04-25       Impact factor: 56.272

10.  Colorectal cancer screening for average-risk North Americans: an economic evaluation.

Authors:  Steven J Heitman; Robert J Hilsden; Flora Au; Scot Dowden; Braden J Manns
Journal:  PLoS Med       Date:  2010-11-23       Impact factor: 11.069

View more
  6 in total

1.  Colorectal Cancer Screening and Prevention in the COVID-19 Era.

Authors:  Rachel B Issaka; Ma Somsouk
Journal:  JAMA Health Forum       Date:  2020-05-13

2.  Extent of Follow-Up on Abnormal Cancer Screening in Multiple California Public Hospital Systems: A Retrospective Review.

Authors:  Elaine C Khoong; Natalie A Rivadeneira; Lucia Pacca; Dean Schillinger; David Lown; Palav Babaria; Neha Gupta; Rajiv Pramanik; Helen Tran; Tyler Whitezell; Ma Somsouk; Urmimala Sarkar
Journal:  J Gen Intern Med       Date:  2022-05-31       Impact factor: 6.473

3.  Systematic Review of Interventions to Increase Stool Blood Colorectal Cancer Screening in African Americans.

Authors:  Siddhartha Roy; Sabrina Dickey; Hsiao-Lan Wang; Alexandria Washington; Randy Polo; Clement K Gwede; John S Luque
Journal:  J Community Health       Date:  2021-02

4.  An observational study of workflows to support fecal testing for colorectal cancer screening in primary care practices serving Medicaid enrollees.

Authors:  Cynthia M Mojica; Rose Gunn; Robyn Pham; Edward J Miech; Ann Romer; Stephanie Renfro; Khaya D Clark; Melinda M Davis
Journal:  BMC Cancer       Date:  2022-01-25       Impact factor: 4.430

Review 5.  From Cancer Epidemiology to Policy and Practice: the Role of a Comprehensive Cancer Center.

Authors:  Robert A Hiatt; Amanda Sibley; Brinda Venkatesh; Joyce Cheng; Niharika Dixit; Rena Fox; Pamela Ling; Tung Nguyen; Debora Oh; Nynikka R Palmer; Rena J Pasick; Michael B Potter; Ma Somsouk; Roberto Ariel Vargas; Maya Vijayaraghavan; Alan Ashworth
Journal:  Curr Epidemiol Rep       Date:  2022-03-21

6.  Perceptions on Barriers and Facilitators to Colonoscopy Completion After Abnormal Fecal Immunochemical Test Results in a Safety Net System.

Authors:  Rachel B Issaka; Ari Bell-Brown; Cyndy Snyder; Dana L Atkins; Lisa Chew; Bryan J Weiner; Lisa Strate; John M Inadomi; Scott D Ramsey
Journal:  JAMA Netw Open       Date:  2021-08-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.